HCS at EB 2021 

Virtual ● April 27 - 30, 2021

For registration information and more detailed information about the conference, see the Experimental Biology 2021 website.  

HCS Scientific Progam

Thursday, April 29th, 2020

12:00noon - 3:00pm
Symposium Chair: Paul Goodwin, PhD


Geographic Information System (GIS) for Tissues and Tumors: Mapping Quantitative Data Into an Anatomical Context

   Histochemistry is the science of identifying biomolecules in context of biological structures. The science is moving from qualitative and descriptive to quantitative and precise. Moreover, adjacent tools have been established that provide quantitative data but lack the structural context (-omics). For example, we can identify and enumerate immune cells, but we struggle with quantitative descriptors of their place relative to important anatomical structures such as blood vessels, extracellular matrix, and even other cells. This session brings together speakers to talk about data analytics in context of geospatial descriptors and biologists (anatomists, pathologists, physiologists, etc.) who are working with spatial mapping of quantitative data within biological systems.


12:00 pm KEYNOTE
Using Telescope as Microscope:
Applying Geospatial Analysis within an Anatomical Context
XunShi, Dartmouth College  


12:30 pm
“Google Maps" for tissue biology - How to find topographic biomarkers?
DenisSchapiro, Harvard Medical School and The Broad Institute of Harvard and MIT 


12:50 pm 
Spatial analysis of multiplex immunohistochemistry data enables systems analysis of hypoxia and improved stratification of lung cancer patient outcomes
Paraq Mallick, Canary Center at Stanford Cancer 


1:10: pm
Mapping the spatial architecture of human tissues in health and disease with Multiplexed Ion Beam Imaging
Erin F. McCaffrey, Stanford University 
1:30 pm Panel Discussion


Symposium Chair: Stephen M. Hewitt MD, PhD
2:00pm – 3:00pm  

Gender Diversity in Innovation Toolkit created by IPO

Mercedes K. Meyer, Ph.D., JD, Faegre, Drinker, Biddle, LLP 


Over 53% of PhDs are awarded to women. Yet, only 12% of recognized innovators in the United States are women.  Women and diverse employees have technical skill and knowledge, yet their contributions are not patented at the same rate as those of their male counterparts. These statistics suggest that our organizations may not be capturing the full contribution of a large segment of our technical workforce – resulting in significant lost opportunity costs (e.g., unpatented inventions, delayed disclosures, etc.)  The insights and perspectives of women are necessary to solve the monumental challenges our organizations face. Join HCS and the Journal of Histochemistry & Cytochemistry as we explore what is needed to help organizations move the needle on achieving gender parity in innovation.